liposomal bupivacaine (1.3%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for liposomal bupivacaine (1.3%), covering 2020-03-20 to 2020-03-20. Get the full timeline:
Most recent: Clinical Trial Update: 0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka [Phase 3]